This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Joo-Sung Yang
Vice President and Head of mRNA R&D at ST Pharm

Profile

Expert in gene therapy, genetic vaccine design and development in the area of infectious diseases & cancer immunotherapy

Diverse experiences with about 30 years of academy and industry in viral immunology, biotechnology, gene therapy, vaccines (conventional, subunit, recombinant viral vectors, DNA & mRNA, edible etc.), and oligonucleotide therapeutics.

DNA-based gene optimization knowhow and platform patent holding for potent immunogens creation

Agenda Sessions

  • Preclinical Safety and Efficacy Studies of mRNA Vaccine STP2104 Against SARS-CoV

    14:00